Jeffrey A. Cramer

Phase I trial of the selective mitochondrial toxin MKT 077 in chemo-resistant solid tumours

David Propper, Jeremy Braybrooke, D.J. Taylor et al. · Annals of Oncology · 1999 · 129 citations · Full text

Mitochondrial Function, Medicine, Pharmacology +6

<i>N</i>-Alkyl Urea Hydroxamic Acids as a New Class of Peptide Deformylase Inhibitors with Antibacterial Activity

C J Hackbarth, Dawn Z. Chen, Jason G. Lewis et al. · Antimicrobial Agents and Chemotherapy · 2002 · 108 citations · Full text

A phase I and pharmacokinetic study of the mitochondrial-specific rhodacyanine dye analog MKT 077.

Carolyn D. Britten, Eric K. Rowinsky, Sharyn D. Baker et al. · PubMed · 2000 · 103 citations

Pharmacokinetic Study, Mkt-077 Plasma Concentrations, Pharmacotherapy +20

Effect of Terbinafine on the Pharmacokinetics and Pharmacodynamics of Desipramine in Healthy Volunteers Identified as Cytochrome P450 2D6 (CYP2D6) Extensive Metabolizers

Soraya Madani, Denise Barilla, Jeffrey A. Cramer et al. · The Journal of Clinical Pharmacology · 2002 · 58 citations

Rapid Fuel Quality Surveillance through Chemometric Modeling of Near-Infrared Spectra

Robert E. Morris, Mark H. Hammond, Jeffrey A. Cramer et al. · Energy & Fuels · 2009 · 58 citations